← Back to patent-cliff list
kisspeptin 112-121
Tier C — Watch / tradekisspeptin 112-121
Massachusetts General Hospital
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：KISS1R
Indications (approved)：闭经, 低促性腺激素性性腺功能减退, Hypogonadism, Infertility, 神经变性, 新冠后遗症, COVID-19, 代谢病
Regional status
US
Phase II
2020-12-02
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of kisspeptin 112-121?
Approved indications include: 闭经, 低促性腺激素性性腺功能减退, Hypogonadism, Infertility, 神经变性, 新冠后遗症, COVID-19, 代谢病.
When does the kisspeptin 112-121 patent expire?
No public expiry year is available for kisspeptin 112-121 yet; this page updates once verified.
How do I get a quote for kisspeptin 112-121 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06